Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

To understand the molecular basis for hemophilia B in patients with little or no circulating Factor IX antigen, a patient who had less than 0.2% circulating Factor IX antigen (Factor IXSeattle 2) was selected for analysis of his Factor IX gene. Genomic DNA fragments from the abnormal gene were clone...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Schach, B G, Yoshitake, S, Davie, E W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113155
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!